Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 3, 1997, Pages 563-569

  Bradford, Patricia A ^a   Urban, Carl ^b,c   Mariano, Noriel ^b   Projan, Steven J ^a   Rahal, James J ^b,c   Bush, Karen ^a,d  

^a PFIZER INC   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFALORIDINE; CEFOTETAN; CEFOXITIN; CEPHAMYCIN; IMIPENEM; OUTER MEMBRANE PROTEIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME PURIFICATION; GENE LOCATION; GENE SEQUENCE; HYDROLYSIS; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SPECTROPHOTOMETRY; STRAIN DIFFERENCE;

EID: 0031026934     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.3.563     Document Type: Article

References (44)

1. Ames, G. F. 1974. Resolution of bacterial proteins by polyacrylamide gel electrophoresis on slabs. J. Biol. Chem. 249:634-644.
2. Bauernfeind, A., Y. Chong, and S. Schweighart. 1989. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17:316-321.
3. Bauernfeind, A., I. Stemplinger, R. Jungwirth, and H. Giamarellou. 1996. Characterization of the plasmidic β-lactamase CMY-2 which is responsible for cephamycin resistance. Antimicrob. Agents Chemother. 40:221-224.
4. CMY-1 gene and its relationship with other β-lactamase genes. Antimicrob. Agents Chemother. 40:1926-1930.
5. Bradford, P. A., C. Urban, A. Jaiswal, N. Mariano, B. A. Rasmussen, S. J. Projan, J. J. Rahal, and K. Bush. 1995. SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.
6. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
7. Bush, K., and S. B. Singer. 1989. Effective cooling allows sonication to be used for liberation of β-lactamases from gram-negative bacteria. J. Antimicrob. Chemother. 24:82-84.
8. Chen, H. Y., and D. M. Livermore. 1993. Activity of cefepime and other β-lactam antibiotics against permeability mutants of Escherichia coli and Klebsiella pneumoniae. J. Antimicrob. Chemother. 32(Suppl. B):63-74.
9. Chow, J. W., and D. M. Shlaes. 1991. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J. Antimicrob. Chemother. 28:499-504.
10. Ehrhardt, A. F., C. C. Sanders, K. S. Thomson, C. Watanakunakorn, and I. Trujillano-Martin. 1993. Emergence of resistance to imipenem in Enterobacter masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin. Clin. Infect. Dis. 17:120-122.
11. BIL-1, a plasmid-mediated class C β-lactamase gene in Escherichia coli. Antimicrob. Agents Chemother. 38:1182-1185.
12. Galleni, M., F. Lindberg, S. Normark, S. Cole, N. Honore, B. Joris, and J.-M. Frere. 1988. Sequence and comparative analysis of three Enterobacter cloacae ampC β-lactamase genes and their products. Biochem. J. 250:753-760.
13. Gazouli, M., L. S. Tzouvelekis, E. Prinarakis, V. Miriagou, and E. Tzelepi. 1996. Transferable cefoxitin resistance in enterobacteria from Greek hospitals and characterization of a plasmid-mediated group 1 β-lactamase (LAT-2). Antimicrob. Agents Chemother. 40:1736-1740.
14. Gonzalez-Leiza, M., J. C. Perez-Diaz, J. Ayala, J. M. Casellas, J. Martinez-Beltran, K. Bush, and F. Baquero. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated β-lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150-2157.
15. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
16. Horii, T., Y. Arakawa, M. Ohta, S. Ichiyama, R. Wacharotayankun, and N. Kata. 1993. Plasmid-mediated AmpC-type β-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum β-lactams, including moxalactam. Antimicrob. Agents Chemother. 37:984-990.
17. MOX-1 gene encoding AmpC-type β-lactamase. Gene 139:93-98.
18. Jacoby, G. A., P. Han, M. Alvarez, and F. Tenover. 1995. Survey of extended-spectrum β-lactamase production in US clinical isolates, abstr. C40, p. 46. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
19. Jaurin, B., and T. Grundström. 1981. ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of β-lactamases of the penicillinase type. Proc. Natl. Acad. Sci. USA 78:4897-4901.
20. Lee, E. H., M. H. Nicolas, M. D. Kitzis, G. Pialoux, E. Collatz, and L. Gutmann. 1991. Association of two resistance mechanisms in a high-level imipenem-resistant clinical isolate of Enterobacter cloacae. Antimicrob. Agents Chemother. 35:1093-1098.
21. Lindberg, F., and S. Normark. 1986. Sequence of the Citrobacter freundii OS60 chromosomal amp C β-lactamase gene. Eur. J. Biochem. 156:441-445.
22. Lugtenberg, B., J. Meijers, R. Peters, P. van der Hoek, and L. V. Alphen. 1975. Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli. FEBS Lett. 58:254-258.
23. Martínez-Martínez, L., S. Hernéndez-Allés, S. Albertí, J. Tomás, V. Benedi, and G. Jacoby. 1996. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 40:342-348.
24. Maslow, J. N., A. M. Slutsky, and R. D. Arbeit. 1993. Application of pulsed-field gel electrophoresis to molecular epidemiology, p. 563-572. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
25. Matthew, M. A., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of isoelectric focusing for detection and identification of beta-lactamases. J. Gen. Microbiol. 88:169-178.
26. Meyer, K. S., C. Urban, J. A. Eagan, B. J. Berger, and J. J. Rahal. 1993. Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins. Ann. Intern. Med. 119:353-358.
27. National Committee for Clinical Laboratory Standards. 1996. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
28. Papanicolaou, G., A. A. Medeiros, and G. A. Jacoby. 1990. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino-and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34:2200-2209.
29. Payne, D. J., N. Woodford, and S. G. B. Amyes. 1992. Characterization of the plasmid mediated β-lactamase BIL-1. J. Antimicrob. Chemother. 30:119-128.
30. Quinn, J. P., D. Miyashiro, D. Sahm, R. Flamm, and K. Bush. 1989. Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 33:1451-1456.
31. Raimondi, A., A. Traverse, and H. Nikaido. 1991. Imipenem-and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins. Antimicrob. Agents Chemother. 35:1174-1180.
32. Rasmussen, B. A. Personal communication.
33. Rasmussen, B. A., P. A. Bradford, J. P. Quinn, J. Wiener, R. A. Weinstein, and K. Bush. 1993. Genetically diverse ceftazidime resistant isolates from a single center: biochemical and genetic characterization of TEM-10 β-lactamases encoded by different nucleotide sequences. Antimicrob. Agents Chemother. 37:1989-1992.
34. Rasmussen, B. A., Y. Gluzman, and F. P. Tally. 1990. Cloning and sequencing of the class B β-lactamase gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrob. Agents Chemother. 34:1590-1592.
35. Rice, L. B., L. L. Carias, L. Etter, and D. M. Shlaes. 1993. Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms. Antimicrob. Agents Chemother. 37:1061-1064.
36. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., vol. 1. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
37. Sanders, W. E., Jr., and C. C. Sanders. 1988. Inducible β-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. Rev. Infect. Dis. 10:830-838.
38. Sykes, R. B., D. P. Bonner, K. Bush, and N. H. Georgopapadakou. 1982. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob. Agents Chemother. 21:85-92.
39. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
40. Thomson, K. S., C. C Sanders, and H. Chmel. 1993. Imipenem resistance in Enterobacter. Eur. J. Clin. Microbiol. Infect. Dis. 12:610-613.
41. LAT-1) found in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 38:2207-2209.
42. Urban, C., K. S. Meyer, N. Mariano, J. J. Rahal, R. Flamm, B. A. Rasmussen, and K. Bush. 1994. Identification of TEM-26 β-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrob. Agents Chemother. 38:392-395.
43. van de Klundert, J. A. M., M. H. van Gestel, G. Meerdink, and S. de Marie. 1988. Emergence of bacterial resistance to cefamandole in vivo due to outer membrane protein deficiency. Eur. J. Clin. Microbiol. Infect. Dis. 7:776-778.
44. Vatopoulos, A. C., A. Philippon, L. S. Tzouvelekis, Z. Kumninou, and N. J. Legakis. 1990. Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates of Klebsiella pneumaniae and Escherichia coli in Greece. J. Antimicrob. Chemother. 26:635-648.